Home > Insider Trading > Filing (0001179110-15-008834)

Filing Details

Accession Number:: 0001179110-15-008834
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-01 20:36:54
Reporting Period:: 2015-05-28

Filing Date:: 2015-06-01
Accepted Time:: 2015-06-01 20:36:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178711	Paratek Pharmaceuticals Inc.	PRTK	Pharmaceutical Preparations (2834)	330960223

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1232258	Ltd. (Cayman) Investments Healthcare Hbm	Governors Square, Suite #4-212-2 23 Lime Tree Bay Ave., West Bay Grand Cayman E9 00000		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-05-28	8,215	$31.52	1,760,045	No	4	S	Direct
Common Stock	Disposition	2015-05-28	2,365	$32.16	1,757,680	No	4	S	Direct
Common Stock	Disposition	2015-05-29	6,300	$29.52	1,751,380	No	4	S	Direct
Common Stock	Disposition	2015-05-29	3,700	$30.25	1,747,680	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.00 to $32.00, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote one (1) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.37, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote two (2) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.9 to $29.89, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote three (3) of this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.97 to $30.45, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the ranges set forth in footnote four (4) of this Form 4.